Cite
HARVARD Citation
Short, N. et al. (2021). An effective chemotherapy‐free regimen of ponatinib plus venetoclax for relapsed/refractory Philadelphia chromosome‐positive acute lymphoblastic leukemia. American journal of hematology. 96 (7), pp. E229-E232. [Online].